Cells, Volume 14, Issue 13
2025 July-1 - 99 articles
Cover Story: Liver fibrosis poses a major global health burden, highlighting the need for advanced in vitro liver models to study disease mechanisms and develop drug therapies. As hepatocyte-induced hepatic stellate cell (HSC) activation is one of the most important drivers of fibrosis development, the inclusion of these cell types in in vitro models is essential. While induced pluripotent stem cell (iPSC)-derived hepatocytes and HSCs provide patient-specific platforms, functional maturation is limited. Herein, we present liver organoids composed of iPSC‑derived hepatocytes and HSCs and demonstrate that activation of RXRA by its ligand 9‑cis‑retinoic acid improves hepatocyte metabolism, maintains HSC quiescence, and enhances response to fibrotic stimuli, offering a refined tool for modelling human liver fibrosis and drug-induced injury. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.